VERTEX PHARMACEUTICALS INC / MA Quarterly Deferred Tax Assets, Gross in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2010 to Q4 2023.
  • Vertex Pharmaceuticals Inc / Ma Deferred Tax Assets, Gross for the quarter ending December 31, 2023 was $2.43B, a 31.9% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.43B +$590M +31.9% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $1.85B +$364M +24.6% Dec 31, 2022 10-K 2024-02-15
Q4 2021 $1.48B +$84.7M +6.07% Dec 31, 2021 10-K 2023-02-10
Q4 2020 $1.4B -$230M -14.1% Dec 31, 2020 10-K 2022-02-09
Q4 2019 $1.63B -$254M -13.5% Dec 31, 2019 10-K 2021-02-11
Q4 2018 $1.88B +$146M +8.39% Dec 31, 2018 10-K 2020-02-13
Q4 2017 $1.73B -$247M -12.5% Dec 31, 2017 10-K 2019-02-13
Q4 2016 $1.98B +$88.7M +4.69% Dec 31, 2016 10-K 2018-02-15
Q4 2015 $1.89B +$324M +20.7% Dec 31, 2015 10-K 2017-02-23
Q4 2014 $1.57B +$191M +13.9% Dec 31, 2014 10-K 2016-02-16
Q4 2013 $1.38B +$166M +13.7% Dec 31, 2013 10-K 2015-02-13
Q4 2012 $1.21B -$118M -8.86% Dec 31, 2012 10-K 2014-02-11
Q4 2011 $1.33B -$38.1M -2.79% Dec 31, 2011 10-K 2013-03-01
Q4 2010 $1.37B Dec 31, 2010 10-K 2012-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.